Does hepatitis B Two Pairs and Half Little Three Yang Need Treatment

Whether two pairs of half small three positive hepatitis B patients need treatment should be comprehensively evaluated in combination with liver function, viral load and other indicators. Little three positive usually refers to positive hepatitis B B surface antigen, hepatitis B B e antibody and hepatitis B core antibody, indicating that the virus replication is weakened but still infectious.

If the liver function is normal and the DNA load of hepatitis B virus is lower than the lower limit of detection, there is usually no need for immediate antiviral treatment, but it is necessary to recheck the liver function, two and a half pairs of hepatitis B virus, virus load and liver ultrasound every 3-6 months. maintaining a regular schedule, avoiding alcohol consumption, and having a balanced diet at this time can help control the condition. It is recommended to consume high-quality protein such as fish and bean products in moderation, limit high-fat foods, and supplement with vitamin B and vitamin E.

If there are abnormal liver function or increased viral load, especially with signs of liver fibrosis, antiviral treatment should be considered. Commonly used drugs include nucleoside analogues such as entecavir tablets and tenofovir disoproxil fumarate tablets, which can inhibit virus replication. Interferon drugs such as pegylated interferon alpha-2b injection can also be used for some patients. During treatment, regular monitoring of renal function, blood phosphorus levels, and virological response is necessary. Regardless of whether treatment is initiated or not, patients with Xiao San Yang should avoid sharing razors and other items that may come into contact with blood with others, and take protective measures during sexual contact. Family members vaccinated with hepatitis B vaccine should regularly test the antibody level. If symptoms such as fatigue, jaundice, and abdominal distension occur, seek medical attention promptly and be alert to the progression of hepatitis or cirrhosis. It is recommended to undergo annual alpha fetoprotein testing and liver elastography to detect the risk of liver cancer early.